Trial Profile
Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 16 Feb 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 11 Dec 2015 New trial record